Biotechnology
Sort by: Featured Most recent Most read Most commented
77 results total, viewing 31 - 40
ProThera Biologics lands $750K from Slater, NIH
East Providence biomedical company ProThera Biologics LLC - led by Rhode Island Hospital scientists Dr. Yow-Pin Lim, above, and Douglas Hixson - has received $750,000 in new funding from the National Institutes of Health and Slater Technology Fund. more
Covidien lands added FDA approval for LigaSure
Covidien PLC has received 510(k) clearance from the U.S. Food and Drug Administration to use its LigaSure curved, small jaw, open sealer/divider in ear, nose and throat procedures. more
| 9/11/12
Covidien’s Mallinckrodt completes CNS Therapeutics acquisition
Medical device maker Covidien PLC’s pharmaceutical arm, Mallinckrodt, has completed its acquisition of St. Paul, Minn.-based CNS Therapeutics Inc. for roughly $100 million. more
| 10/3/12
Norman Prince Neurosciences Institute lands $600K for brain research, lecture series
The Norman Prince Neurosciences Institute at Rhode Island Hospital was awarded three philanthropic gifts totaling nearly $600,000 to improve brain science in the state of Rhode Island by supporting research and establishing a lecture series. more
NIH awarded $147M to R.I. in FY2012
During the fiscal year ended June 30, the National Institutes of Health awarded a total of $146.96 million in grants to Rhode Island hospitals, universities and companies. more
R.I. companies honored at Museum of Science’s ‘Invented Here’ awards
IlluminOss Medical Inc. and G-Form LLC were two of the four companies honored at the Boston Museum of Science’s second annual “Invented Here” awards. more
| 10/15/12
IlluminOss lets go president and CEO
(Updated, 5:20 p.m.) IlluminOss Medical Inc. terminated President and CEO Scott Rader Monday, company founder Robert Rabiner said Wednesday. more
EDC approves Alexion tax cut
The R.I. Economic Development Corporation approved a corporate tax cut Monday night for Alexion Pharmaceuticals under the state’s Jobs Development Act. more
Amgen sales rise to $4.2B in 3Q
Thousand Oaks, Calif.–based Amgen, one of the world’s largest biotechnology companies, saw revenue rise 9.5 percent to $4.3 billion in the three months ended Sept. 30 from $3.9 billion during the same period in 2011. more
| 10/24/12
Amgen places bet on heart drug as rivals go after sales
Amgen Inc., the world’s largest biotechnology company, is developing a new anti-cholesterol medicine by 2015 that it sees as its best shot to offset reduced sales when its popular anemia drugs lose exclusivity. more
« Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 … 8 | Next »
Calendar
PBN Hosted
Events

The 2nd Annual Healthiest Employers event will recognize employers who have strong, effective Health and Wellness programs in the region. Deadline for enrollment is June 28th.
Advertisement
National
Local
Latest News